On Monday, the FDA approved Truvada, the first medication intended to prevent HIV infections in people having sex with infected partners. In clinical trials where HIV-negative individuals had unprotected sex with multiple partners, including some with HIV, the pill reduced the risk of infection by 42 percent compared with a placebo. Another trial with heterosexual couples where one partner was infected found that Truvada, which is taken daily, reduced the risk by 75 percent. The FDA warned that the drug, which will cost patients about $450 a year, should be used in conjunction with other prevention methods.
THE WEEK'S AUDIOPHILE PODCASTS: LISTEN SMARTER
- Here comes the Pentagon's newest space plane
- 43 TV shows to watch in 2014
- Extreme haunted houses: Inside Halloween's most terrifying new trend
- 6 things the happiest families all have in common
- The U.S. is about to sell weapons to Vietnam. That's bad news for China.
- Did the media get Ferguson wrong?
- What the Middle Ages can tell us about the GOP's big charity myth
- How to be the most productive person in your office — and still get home by 5:30 p.m.
- The real story behind Deliver Us From Evil
- America's anti-feminist mega-corporations' toxic disregard for women must stop
Subscribe to the Week